A novel Oprm1-Cre mouse maintains endogenous expression, function and enables detailed molecular characterization of

Juliet Mengaziol1, Amelia D Dunn1, Gregory Salimando2

  • 1Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Plos One
|December 19, 2022
PubMed

Insights

Researchers developed a novel mouse model targeting μ-opioid receptors (MORs) to study opioid addiction mechanisms. This tool enables detailed investigation into cellular and behavioral effects of opioids, advancing addiction research.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Opioid addiction remains a significant challenge, with μ-opioid receptors (MORs) being central to both therapeutic effects and abuse potential.
  • Current understanding of the cellular mechanisms driving opioid addiction is incomplete, despite extensive research on MOR signaling pathways.
  • Existing opioid therapies and addictive substances interact with MORs, highlighting the need for precise tools to study these interactions.

Purpose of the Study:

  • To develop and validate a novel MOR-specific Cre mouse line for mechanistic investigation of opioid-mediated phenotypes.
  • To enable cell-type specific analysis of MOR-expressing neurons in the context of opioid use and withdrawal.
  • To facilitate deeper understanding of the cellular and molecular underpinnings of opioid addiction.

Main Methods:

  • Generation of a MOR-specific Cre mouse line by inserting Cre recombinase into the MOR 3'UTR.
  • Validation of MOR expression specificity and fidelity across the brain.
  • Crossing MOR-Cre mice with floxed GFP reporter lines (RosaLSLSun1-sfGFP or RosaLSL-GFP-L10a) for lineage tracing and cell-type specific RNA sequencing via TRAP (Translating Ribosome Affinity Purification).

Main Results:

  • The MOR-Cre mouse line demonstrated specific and faithful MOR expression in the brain.
  • No significant behavioral differences in response to morphine were observed compared to wild-type mice.
  • TRAP RNA sequencing was successfully performed on striatal MOR+ neurons following opioid withdrawal, demonstrating the tool's utility.

Conclusions:

  • The novel MOR-specific Cre mouse line is a validated and effective tool for studying opioid biology.
  • This mouse line provides unprecedented opportunities to investigate MOR-related cellular and behavioral phenotypes.
  • The tool will significantly advance research into the mechanisms of opioid addiction and potential therapeutic strategies.